PARD - Poniard Pharmaceuticals Incorporated

Your Recent Quotes: 0 | 0

Poniard Pharmaceuticals Incorporated

TRADE NOW Related Information and Financials

NASDAQ: PARD, Health Care

Price Glossary Definition
3.40 0.07
2.10%
1/09/09 3:59
Open
3.61
Prev Close
3.33
Volume
82,246
52 Wk. Range
1.05- 6.39
Year-to-Date Performance Glossary Definition
UP 72.54%
Latest Dividend for PARD
Dividend
N/A
Yield
0.00
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
-2.38
 
0.00
 
13.50
PARD
Sect. Av.
S&P 500
Market Cap
106,492,200
Outstanding Shares
34,688,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy PARD Rating Report
Rating History for PARD
Target Price (1Yr)
High
10.00
Revenue
10,714,000

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
N/A
-1.00
0.00
Net Income
N/A
0.69
0.00
EPS
N/A
-0.73
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-3.75
-25.00
0.00
Earnings Per Share($)

12/2005
 
 
 
-3.84
12/2006
 
 
 
-1.37
12/2007
 
 
 
-1.08

Earnings for PARD
EBITDA
-34,324,000
Revenue
0
Outside Analyst Rating History

1/9/09
4
Buy
1/9/09
0
Hold
1/9/09
0
Sell

Jim Cramer Portfolio
Find out now if PARD is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Latest PARD Headlines
Biotech Clinical Trials to Watch in 2009
Senior Writer Adam Feuerstein provides a list of biotech and drug clinical trials expected to move stocks in 2009.

10:04AM 12/18/08

View All Headlines for PARD
Understanding the Market
Our Experts' Take at RealMoney for Poniard Pharmaceuticals Incorporated
Pockets of Positive Action
Traders are cycling back into 'slow motion' stocks and realizing that they oversold Wal-Mart.

12:39PM 01/09/09

Here's the Play on the Ho-Hum Jobs Number
Once again, sentiment is in the driver's seat.

8:58AM 01/09/09

More Experts' Takes on PARD
View All TheStreet Experts
Premium Stock Ideas
Is Cramer trading PARD in his Action Alerts Plus Portfolio?